Related Experiment Video
Updated: Jan 1, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
The role of lncRNA MALAT1 in cardiovascular disease
Youyou Yan1,2, Dandan Song3, Xianjing Song1
1Department of Cardiology, Second Hospital of Jilin University, Changchun, China.
Abstract:
Cardiovascular disease (CVD) is the first leading cause of death worldwide. Understanding the molecular mechanism of signaling pathways involved in pathology of CVD is benefit for targeted therapeutics. Recently, long non-coding RNAs (lncRNAs) are found and involved in regulation of pathology of CVD at different levels. Among them, MALAT1 attracted more attention as it was profoundly expressed in endothelial cells or cardiomyocytes in response to the risk factors of CVD, such as hypoxia, high glucose, cytokine, and oxidative stress. In this review, we summarize recent progresses in research on the molecular mechanism of MALAT1 on regulating the pathophysiological processes of CVD as well as its potential therapeutic applications.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Coronary Artery Disease I: Introduction
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons

